Complementary and alternative medicine use among patients with thoracic malignancies
- 300 Downloads
Complementary and alternative medicine (CAM) use has been increasing among cancer patients. This study characterizes the use of CAM among patients with thoracic malignancies.
This cross sectional study was conducted at a National Cancer Institute-designated comprehensive cancer center among adult patients diagnosed with thoracic malignancies. The primary outcome was a self-reported use of CAM, defined as the use of any type of CAM beyond routine vitamin/mineral supplementation alone. A logistic regression model was developed to explore predictors of CAM use.
A total of 108 patients completed a standardized survey (59 % response rate). Overall, 42 % of respondents reported the use of at least one type of CAM. Users and non-users of CAM did not differ based upon demographics, diagnosis, staging, smoking status, quality of life, or perceived understanding of cancer diagnosis. In the multivariate analysis, patients who reported feeling fearful about their future were four times more likely to be CAM users when compared to those who did not specify this emotion (odds ratio = 4.18; 95 % CI = 1.23–14.12; p = 0.02). Commonly cited reasons for CAM use were to support one’s self, boost immunity, and for improvements in emotional and/or spiritual well-being.
Prevalence of CAM use among cancer patients in this study was similar to the general US population. Feeling fearful about the future was associated with CAM use. Results suggest that patients may be turning to CAM as a therapeutic adjunct to actively cope with emotional distress surrounding the cancer experience.
KeywordsLung neoplasms/complications/*therapy Complementary therapies/*utilization Cross-sectional studies
Conflict of interest
This research was funded in part by a Physician Training Award in Preventive Medicine from the American Cancer Society (Dr. Mahoney, PI) supporting specialized training in Cancer Prevention and Control for Dr. Bismark. The study was conducted while Dr. Bismark was completing a residency at the University at Buffalo. She does not have any other financial relationship with the American Cancer Society to disclose.
Additionally, Dr. Bismark maintains full control of all primary data. She will agree to allow the journal to have access to and review data if requested.
This research was funded in part by a Physician Training Award in Preventive Medicine from the American Cancer Society (Dr. Mahoney, PI) supporting specialized training in Cancer Prevention and Control for Dr. Bismark.
- 1.WHO (2008) Cancer Fact Sheets. http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed 21 Dec 2011
- 2.NCI (2011) SEER Stat Fact Sheets. http://seer.cancer.gov/statfacts/html/lungb.html. Accessed 25 March 2013
- 8.NCCAM (2008) What is complementary and alternative medicine? [NCCAM CAM Basics]. http://nccam.nih.gov/health/whatiscam/. Accessed 21 Dec 2011
- 9.Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):85–120PubMedGoogle Scholar
- 10.Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. National health statistics reports (12):1–23Google Scholar
- 17.Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol Off J Am Soc Clin Oncol 18(13):2505–2514Google Scholar
- 18.Boehmer L, Waqar S, Butler S, Sezhiyan A, Govindan R (2011) Summary of presentations from the 46th annual meeting of the American Society of Clinical Oncology (2010): focus on supportive care issues related to lung cancer. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 6(3):645–649. doi: 10.1097/JTO.0b013e318200f95d CrossRefGoogle Scholar
- 19.Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, Pietanza MC, Cassileth BR (2013) Complementary therapies and integrative medicine in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e420S–e436S. doi: 10.1378/chest.12-2364 PubMedCrossRefGoogle Scholar
- 20.Molassiotis A, Panteli V, Patiraki E, Ozden G, Platin N, Madsen E, Browall M, Fernandez-Ortega P, Pud D, Margulies A (2006) Complementary and alternative medicine use in lung cancer patients in eight European countries. Complement Ther Clin Pract 12(1):34–39. doi: 10.1016/j.ctcp.2005.09.007 PubMedCrossRefGoogle Scholar
- 22.Lovgren M, Wilde-Larsson B, Hok J, Levealahti H, Tishelman C (2011) Push or pull? Relationships between lung cancer patients’ perceptions of quality of care and use of complementary and alternative medicine. Eur J Oncol Nurs: Off J Eur Oncol Nurs Soc 15(4):311–317. doi: 10.1016/j.ejon.2010.10.004 CrossRefGoogle Scholar
- 25.Naing A, Stephen SK, Frenkel M, Chandhasin C, Hong DS, Lei X, Falchook G, Wheler JJ, Fu S, Kurzrock R (2011) Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Cancer 117(22):5142–5150. doi: 10.1002/cncr.26164 PubMedCrossRefGoogle Scholar
- 31.Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD (2006) Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Res Treat 100(2):219–227. doi: 10.1007/s10549-006-9239-3 PubMedCrossRefGoogle Scholar
- 32.McDermott CL, Blough DK, Fedorenko CR, Arora NK, Zeliadt SB, Fairweather ME, Oakley-Girvan I, Van Den Eeden SK, Ramsey SD (2012) Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 20(1):65–73. doi: 10.1007/s00520-010-1055-y CrossRefGoogle Scholar
- 34.Barnes PM, Powell-Griner E, McFann K, Nahin RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Advance data (343):1–19Google Scholar
- 38.Stein KD, Kaw C, Crammer C, Gansler T (2009) The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors: a report from the American Cancer Society’s studies of cancer survivors. Cancer 115(18 Suppl):4397–4408. doi: 10.1002/cncr.24591 PubMedCrossRefGoogle Scholar
- 43.Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89(4):873–880PubMedCrossRefGoogle Scholar
- 47.Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL (2013) Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 105(16):1230–1238. doi: 10.1093/jnci/djt181 PubMedCrossRefGoogle Scholar
- 48.Balogh EP, Ganz PA, Murphy SB, Nass SJ, Ferrell BR, Stovall E (2011) Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an Institute of Medicine workshop. Oncologist 16(12):1800–1805. doi: 10.1634/theoncologist.2011-0252 PubMedCentralPubMedCrossRefGoogle Scholar